CSYZ:XETRA:XETRA-Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD (EUR)

ETF | Others |

Last Closing

USD 100.92

Change

+2.23 (+2.26)%

Market Cap

USD 0.22B

Volume

6.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.32 (-0.62%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.73%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.20 (-0.74%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.38%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.23 (-0.94%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.08 (-0.05%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

-0.48 (-1.10%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

-1.36 (-0.96%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.66%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.74 (-0.14%)

USD 80.38B

ETFs Containing CSYZ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.77% 13% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.77% 13% F 19% F
Trailing 12 Months  
Capital Gain 2.04% 26% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.04% 25% F 32% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -4.24% 13% F 16% F
Dividend Return -4.00% 13% F 15% F
Total Return 0.24% 10% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 10.54% 60% D- 68% D+
Risk Adjusted Return -37.98% 20% F 19% F
Market Capitalization 0.22B 50% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.